Blueshift Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,314
| Closed | -$287K | – | 355 |
|
|
2023
Q2 | $287K | Buy |
+2,314
| New | +$287K | 0.11% | 229 |
|
|
2022
Q2 | – | Sell |
-1,699
| Closed | -$264K | – | 840 |
|
|
2022
Q1 | $264K | Buy |
1,699
+63
| +4% | +$9.79K | 0.02% | 657 |
|
|
2021
Q4 | $208K | Sell |
1,636
-5,657
| -78% | -$719K | 0.02% | 750 |
|
|
2021
Q3 | $950K | Buy |
7,293
+6,013
| +470% | +$783K | 0.05% | 421 |
|
|
2021
Q2 | $227K | Sell |
1,280
-5,047
| -80% | -$895K | 0.01% | 815 |
|
|
2021
Q1 | $1.04M | Buy |
6,327
+5,049
| +395% | +$830K | 0.11% | 271 |
|
|
2020
Q4 | $211K | Buy |
+1,278
| New | +$211K | 0.03% | 609 |
|
|
2019
Q1 | – | Sell |
-2,513
| Closed | -$312K | – | 830 |
|
|
2018
Q4 | $312K | Buy |
+2,513
| New | +$312K | 0.06% | 479 |
|